VIOKACE Rx

Select the drug indication to add to your list

VIOKACE

Digestive and biliary disorders
Only 4 drugs may be compared at once

Generic Name and Formulations:

Lipase/protease/amylase: 10440Units/39150Units/39150Units; 20880Units/78300Units/78300Units; tabs.

Company:

Allergan

Select therapeutic use:

Indications for VIOKACE:

Treatment of exocrine pancreatic insufficiency in adults due to chronic pancreatitis or pancreatectomy, in combination with a proton pump inhibitor.

Adult:

See literature. Start at the lowest recommended dose and increase gradually. Individualize based on clinical symptoms, the degree of steatorrhea present, and the fat content of the diet. Swallow whole; do not crush or chew tabs. Do not allow drug to remain in mouth. Initially 500 lipase units/kg per meal. Max: 2500 lipase units/kg per meal (or ≤10000 lipase units/kg per day), or <4000 lipase units/g fat ingested per day.

Children:

Not established.

Warnings/Precautions:

Not interchangeable with any other pancrelipase products. Fibrosing colonopathy (with high doses); risk of stricture formation (monitor). Pork allergy. Potential viral transmission. Gout. Renal impairment. Hyperuricemia. Contents irritating to mucosa. Lactose intolerance. Pregnancy (Cat.C). Nursing mothers.

Pharmacological Class:

Pancreatic enzymes (porcine).

Adverse Reactions:

Biliary tract stones, anal pruritus; fibrosing colonopathy, hyperuricemia, allergic reactions.

How Supplied:

Tabs—100

VIOKACE 10440 units tablets (Qty:270)

appx. price $869.00